Thomas Vanwolleghem

Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine: a randomised controlled trial

Isabel Leroux‐Roels, Astrid Borkowski, Thomas Vanwolleghem et al. · The Lancet · 2007 · 500 citations

Vaccination, Cross-protection, Vaccine Development +9

Cell culture-grown hepatitis C virus is infectious <i>in vivo</i> and can be recultured <i>in vitro</i>

Brett D. Lindenbach, Philip Meuleman, Thomas Vanwolleghem et al. · Proceedings of the National Academy of Sciences · 2006 · 424 citations · Full text

Viral Replication, Hepatitis C Virus, Hcv Life Cycle +17

Anti-CD81 antibodies can prevent a hepatitis C virus infection in vivo

Philip Meuleman, Joseph Hesselgesser, Matthew Paulson et al. · Hepatology · 2008 · 215 citations

Off-Therapy Response After Nucleos(t)ide Analogue Withdrawal in Patients With Chronic Hepatitis B: An International, Multicenter, Multiethnic Cohort (RETRACT-B Study)

Grishma Hirode, Hannah Choi, Chien‐Hung Chen et al. · Gastroenterology · 2021 · 177 citations

Ide Analogue Withdrawal, Hepatology, Viral Hepatitis +7

Shear‐wave elastography of the liver and spleen identifies clinically significant portal hypertension: A prospective multicentre study

Christian Jansen, Christopher Bogs, Wim Verlinden et al. · Liver International · 2016 · 149 citations · Full text